Nuvation Bio Inc. (NUVB)

Nuvation Bio Statistics

Total Valuation

Nuvation Bio has a market cap or net worth of $868.34 million. The enterprise value is $330.40 million.

Market Cap	868.34M
Enterprise Value	330.40M

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

Nuvation Bio has 336.57 million shares outstanding. The number of shares has increased by 9.33% in one year.

Current Share Class	335.57M
Shares Outstanding	336.57M
Shares Change (YoY)	+9.33%
Shares Change (QoQ)	+11.78%
Owned by Insiders (%)	24.97%
Owned by Institutions (%)	42.55%
Float	207.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	285.43
Forward PS	n/a
PB Ratio	1.73
P/TBV Ratio	1.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	152.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.57, with a Debt / Equity ratio of 0.02.

Current Ratio	9.57
Quick Ratio	9.37
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-533.52

Financial Efficiency

Return on equity (ROE) is -95.54% and return on invested capital (ROIC) is -14.87%.

Return on Equity (ROE)	-95.54%
Return on Assets (ROA)	-13.98%
Return on Capital (ROIC)	-14.87%
Revenue Per Employee	$42,392
Profits Per Employee	-$10.44M
Employee Count	51
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +86.96% in the last 52 weeks. The beta is 1.36, so Nuvation Bio's price volatility has been higher than the market average.

Beta (5Y)	1.36
52-Week Price Change	+86.96%
50-Day Moving Average	2.52
200-Day Moving Average	2.78
Relative Strength Index (RSI)	50.14
Average Volume (20 Days)	2,218,539

Short Selling Information

The latest short interest is 11.32 million, so 3.36% of the outstanding shares have been sold short.

Short Interest	11.32M
Short Previous Month	21.42M
Short % of Shares Out	3.36%
Short % of Float	5.46%
Short Ratio (days to cover)	7.28

Income Statement

In the last 12 months, Nuvation Bio had revenue of $2.16 million and -$532.28 million in losses. Loss per share was -$2.23.

Revenue	2.16M
Gross Profit	-700,000
Operating Income	-134.45M
Pretax Income	-510.72M
Net Income	-532.28M
EBITDA	-133.93M
EBIT	-134.45M
Loss Per Share	-$2.23

Balance Sheet

The company has $549.14 million in cash and $11.19 million in debt, giving a net cash position of $537.94 million or $1.60 per share.

Cash & Cash Equivalents	549.14M
Total Debt	11.19M
Net Cash	537.94M
Net Cash Per Share	$1.60
Equity (Book Value)	502.71M
Book Value Per Share	1.50
Working Capital	505.95M

Cash Flow

In the last 12 months, operating cash flow was -$99.14 million and capital expenditures -$188,000, giving a free cash flow of -$99.33 million.

Operating Cash Flow	-99.14M
Capital Expenditures	-188,000
Free Cash Flow	-99.33M
FCF Per Share	-$0.30

Margins

Gross Margin	-32.38%
Operating Margin	-6,218.59%
Pretax Margin	-24,619.84%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-5,871.64%

Dividends & Yields

Nuvation Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.33%
Shareholder Yield	-9.33%
Earnings Yield	-61.30%
FCF Yield	-11.44%

Analyst Forecast

The average price target for Nuvation Bio is $6.33, which is 139.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.33
Price Target Difference	139.15%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	5.32%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nuvation Bio has an Altman Z-Score of 3.19 and a Piotroski F-Score of 1.

Altman Z-Score	3.19
Piotroski F-Score	1